Polyzou A, Pournaras S, Dafni U, Sofianou D, Christeli E, Patrinos S, Tsakris A
Department of Microbiology, Hippokration University Hospital, Thessaloniki, Greece.
J Clin Lab Anal. 2004;18(3):211-4. doi: 10.1002/jcla.20025.
A seroepidemiological study was conducted on a representative sample of the northern Greek population (healthy individuals, age range=1 day to 80 years) to assess the prevalence of antibodies to pertussis toxin (PT) and filamentous hemagglutinin (FHA). Antibody concentrations were significantly elevated with age (analysis of variance (ANOVA), P<0.001). In addition, a significant increase in antibody levels was detected in subjects >50 years old compared to children aged 5-10 years (post-hoc Scheffe analysis, P=0.007). These data suggest that pertussis occurs frequently in Greek adults, and that sometimes a fifth booster vaccine dose is not given after the second year of life. Routine revaccination with the acellular vaccine for children >4 years of age, adolescents, and adults should be considered in order to ensure effective protection of the whole population.
对希腊北部人群(健康个体,年龄范围为1天至80岁)的一个代表性样本进行了血清流行病学研究,以评估抗百日咳毒素(PT)和丝状血凝素(FHA)抗体的流行情况。抗体浓度随年龄显著升高(方差分析(ANOVA),P<0.001)。此外,与5-10岁儿童相比,50岁以上受试者的抗体水平显著升高(事后Scheffe分析,P=0.007)。这些数据表明,百日咳在希腊成年人中频繁发生,并且有时在生命第二年之后未接种第五剂加强疫苗。应考虑对4岁以上儿童、青少年和成年人进行无细胞疫苗常规再接种,以确保对整个人群的有效保护。